Home > Healthcare > Medical Devices > Diagnostic Devices > Transcutaneous Oximetry Systems Market

Transcutaneous Oximetry Systems Market Trends

  • Report ID: GMI5829
  • Published Date: May 2023
  • Report Format: PDF

Transcutaneous Oximetry Systems Market Trends

The increasing focus on patient monitoring during diagnosis and treatment is anticipated to drive the transcutaneous oximetry systems industry growth in the coming years. The rising prevalence of preterm birth, peripheral vascular disorders, and chronic limb-threatening ischemia among others has significantly increased the necessity to frequently monitor the blood oxygen saturation level of patients. The transcutaneous oximetry system determines the vital sign parameters such as TCOM or TcPO2 that help the physicians to decide the future course of action for medications and treatment. Patient monitoring is proving to be a critical mechanism during surgical interventions as it helps to determine the response of the patient during the procedure. Hospitals and ambulatory surgical centers involved in the treatment of Peripheral Vascular disease and diabetic foot ulcers are installed with advanced transcutaneous monitors to continuously monitor the patient to determine the oxygen level of the tissue below the skin.
 

Furthermore, several government organizations across the globe have implemented strict regulations and recommendations to continuously monitor the oxygen levels of patients suffering from chronic diseases. Furthermore, hospitals and clinics have focused more on oximeters for anesthesia monitoring during surgical procedures. The surge in the prevalence & morbidity associated with chronic respiratory diseases is amongst the key variables that are set to prove beneficial for the market. Industry players and governments are collaboratively emphasizing on patient safety during operation that has resulted in aligning the transcutaneous oximetry systems as an essential device in healthcare facilities. As a result, the surging in-patient hospitalization for various diagnosis and treatments is projected to fuel the transcutaneous oximetry systems adoption.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Market size for transcutaneous oximetry systems was valued at around USD 132 million in 2022 and is estimated to reach over USD 223 million by the end of 2032 attributed to increasing technological improvements.

The multichannel segment was valued at more than USD 96 million in 2022 and is set to grow at a robust pace through 2032 owing to the rising awareness of benefits related to the use of multichannel transcutaneous oxygen monitors.

The U.S. dominated the North America transcutaneous oximetry systems industry and is anticipated to reach around USD 91 million by 2032 driven by the growing prevalence of preterm birth and the surging adoption of advanced patient monitoring systems.

The global transcutaneous oximetry systems industry comprises Advin Health Care, Cephalon, Medicap Homecare GmbH, Perimed AB, Koninklijke Philips N.V., and many other prominent firms.

Transcutaneous Oximetry Systems Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 8
  • Tables & Figures: 363
  • Countries covered: 31
  • Pages: 180
 Download Free Sample